Delta-Fly Pharma, Inc.(JP:4598)
Â¥62.00+2.00 (+3.33%)
JP:4598
Delta-Fly Pharma, Inc. financials statements
Â¥62.00
At close:+2.00 (+3.33%)
Want to see JP:4598 full AI Analyst Report?
Delta-Fly Pharma, Inc. (4598) Ratios
1 Followers
Delta-Fly Pharma, Inc. Ratios
JP:4598's free cash flow for Q1 2026 was ¥0.00. For the 2026 fiscal year, JP:4598's free cash flow was increased by ¥0.00 and operating cash flow was ¥0.00. See a summary of the company’s cash flow.
| Ratios | Mar 26 | Mar 26 | Mar 25 | Mar 24 | Mar 23 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 2.52 | 0.98 | 5.93 | 7.49 | 14.05 |
| Quick Ratio | 2.52 | 0.98 | 5.93 | 7.49 | 14.05 |
| Cash Ratio | 2.16 | 0.68 | 5.87 | 7.30 | 13.91 |
| Solvency Ratio | -10.99 | -7.64 | -5.91 | -11.48 | -10.59 |
| Operating Cash Flow Ratio | -11.72 | -7.32 | -5.30 | -11.27 | -10.31 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | ¥ 238.14M | ¥ -4.75M | ¥ 1.19B | ¥ 750.60M | ¥ 1.19B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt-to-Equity Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.56 | 7.26 | 1.20 | 1.15 | 1.07 |
| Debt Service Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | -512.63 |
| Interest Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | -511.69 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.35 |
| Net Debt to EBITDA | 0.20 | 0.09 | 1.01 | 0.64 | 1.32 |
| Profitability Margins | |||||
| Gross Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 100.00% |
| EBIT Margin | 0.00% | 0.00% | 0.00% | 0.00% | -320.49% |
| EBITDA Margin | 0.00% | 0.00% | 0.00% | 0.00% | -320.00% |
| Operating Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | -320.49% |
| Pretax Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | -321.35% |
| Net Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | -322.43% |
| Continuous Operations Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | -322.43% |
| Net Income Per EBT | 100.15% | 100.15% | 100.18% | 100.23% | 100.34% |
| EBT Per EBIT | 100.61% | 101.14% | 101.67% | 100.76% | 100.27% |
| Return on Assets (ROA) | -396.28% | -659.16% | -96.96% | -146.53% | -73.04% |
| Return on Equity (ROE) | -619.58% | -4785.01% | -115.96% | -167.95% | -78.44% |
| Return on Capital Employed (ROCE) | -614.92% | -4723.63% | -113.86% | -166.31% | -77.97% |
| Return on Invested Capital (ROIC) | -614.92% | -4723.63% | -113.86% | -166.31% | -77.97% |
| Return on Tangible Assets | -396.28% | -659.16% | -96.96% | -146.53% | -73.04% |
| Earnings Yield | -34.01% | -72.03% | -33.02% | -38.95% | -29.66% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Payables Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 7.51 |
| Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.23 |
| Working Capital Turnover Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.19 |
| Cash Conversion Cycle | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Sales Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Cycle | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -208.47 | -134.50 | -177.95 | -229.97 | -173.61 |
| Free Cash Flow Per Share | -208.48 | -134.50 | -178.11 | -230.02 | -173.61 |
| Dividend Paid and CapEx Coverage Ratio | -15815.32 | 0.00 | -1130.40 | -4059.34 | 0.00 |
| Capital Expenditure Coverage Ratio | -15815.32 | 0.00 | -1130.40 | -4059.34 | 0.00 |
| Operating Cash Flow Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Cash Flow to Sales Ratio | 0.00 | 0.00 | 0.00 | 0.00 | -3.13 |
| Free Cash Flow Yield | -36.26% | -68.97% | -29.59% | -38.21% | -28.84% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -2.94 | -1.39 | -3.03 | -2.57 | -3.37 |
| Price-to-Sales (P/S) Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 10.87 |
| Price-to-Book (P/B) Ratio | 18.22 | 66.43 | 3.51 | 4.31 | 2.64 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -2.76 | -1.45 | -3.38 | -2.62 | -3.47 |
| Price-to-Operating Cash Flow Ratio | -2.76 | -1.45 | -3.38 | -2.62 | -3.47 |
| Price-to-Earnings Growth (PEG) Ratio | 1.83 | 0.05 | 0.20 | -0.08 | 0.72 |
| Enterprise Value Multiple | -2.77 | -1.32 | -2.08 | -1.94 | -2.08 |
| Enterprise Value | 4.72B | 2.11B | 2.91B | 2.57B | 1.99B |
| EV to EBITDA | -2.77 | -1.32 | -2.08 | -1.94 | -2.08 |
| EV to Sales | 0.00 | 0.00 | 0.00 | 0.00 | 6.64 |
| EV to Free Cash Flow | -2.57 | -1.36 | -2.27 | -1.97 | -2.12 |
| EV to Operating Cash Flow | -2.57 | -1.36 | -2.28 | -1.97 | -2.12 |
| Tangible Book Value Per Share | 31.57 | 2.94 | 171.42 | 139.63 | 227.66 |
| Shareholders’ Equity Per Share | 31.57 | 2.94 | 171.42 | 139.63 | 227.66 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
| Revenue Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 55.38 |
| Net Income Per Share | -195.58 | -140.45 | -198.78 | -234.51 | -178.58 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 1.01 | 1.01 | 1.02 | 1.00 | 1.00 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 3.14 |
| SG&A to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 1.07 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 1.07 | 0.96 | 0.90 | 0.98 | 0.98 |
Currency in JPY

